Deirdre Hooper, MD
Dermatology · New Orleans, LANPI 1114973617
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (55.7%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. 39 manufacturers reported payments, led by Galderma Laboratories, L.p. at 53.4% of the total. Reporting peaked in 2021 at $34,851 and has fallen 72.7% since, to $9,512 in 2025. Among dermatology clinicians in LA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 719 payments — averaging $200.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Galderma Laboratories, L.p.$77K
- AbbVie$51K
- Mayne Pharma Commercial LLC$7K
- Merz North America, Inc.$3K
- Sun Pharmaceutical Industries Inc.$610
- LEO Pharma Inc.$604
- plus $5K from 33 others
Across 612 payments — averaging $5080.22 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$1.8M
- Incyte Corporation$574K
- UCB SA$378K
- VYNE Pharmaceuticals Inc.$120K
- Pfizer$85K
- Glenmark Pharmaceuticals Inc., USA$59K
- plus $117K from 4 others
What the payments were for
- Consulting fees$41,28829%
- Speaking & faculty fees$80,13556%
- Travel & lodging$5,8054%
- Food & beverage$15,74011%
- Education$8361%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$143,804 in reported general payments places this provider in the 90th percentile of 189 dermatology providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Fluorouracil | 32 | $2,033 |
| Ketoconazole | 60 | $1,082 |
| Doxycycline Hyclate | 37 | $1,036 |
| ValacyclovirValacyclovir Hcl | 44 | $758 |
| Clobetasol Propionate | 22 | $694 |
| Ciclopirox | 18 | $527 |
| Triamcinolone Acetonide | 63 | $518 |
| Mupirocin | 37 | $372 |
| Minoxidil | 18 | $90 |
Paid to pharmacies, not to this prescriber.
Other dermatology in New Orleans
- William ClaiborneNew Orleans$374K
- Erin BohNew Orleans$277K
- Mara HaseltineNew Orleans$276K
- Julie MermilliodNew Orleans$222K
- Sarah JacksonNew Orleans$167K
- Patricia HickhamNew Orleans$12K
- Stephen KlingerNew Orleans$11K
- Katherine HolcombMetairie$411K
- Blair BuddenLafayette$329K
- Sarah HaydelHouma$265K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.